Related references
Note: Only part of the references are listed.Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection
Neha Sharma et al.
INFLAMMOPHARMACOLOGY (2017)
Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease
Ashutosh Kumar et al.
MOLECULAR NEUROBIOLOGY (2016)
Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations
Neha Sharma et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Characterization of the lipopolysaccharide induced Model of Parkinson's disease: Role of oxidative stress and neuroinflammation
Neha Sharma et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells
Ashutosh Kumar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Curcumin Prevents Aggregation in α-Synuclein by Increasing Reconfiguration Rate
Basir Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
a-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
Zane S. Martin et al.
JOURNAL OF NEUROCHEMISTRY (2012)
NADPH Oxidase 1 Mediates α-Synucleinopathy in Parkinson's Disease
Ana Clara Cristovao et al.
JOURNAL OF NEUROSCIENCE (2012)
Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
Kazunari Sekiyama et al.
PARKINSONS DISEASE (2012)
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
Mario Caruana et al.
FEBS LETTERS (2011)
Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
Nelson Ferreira et al.
FEBS LETTERS (2011)
Neuroinflammation in Parkinson's disease
Etienne C. Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2011)
Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism
Zhaohui Liu et al.
PHARMACOLOGICAL RESEARCH (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Min S. Wang et al.
BMC NEUROSCIENCE (2010)
Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons
Guy C. Brown et al.
MOLECULAR NEUROBIOLOGY (2010)
Astrocytes and Therapeutics for Parkinson's Disease
Phillip M. Rappold et al.
NEUROTHERAPEUTICS (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Curcumin, inflammation, ageing and age-related diseases
E Sikora et al.
Immunity & Ageing (2010)
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator
Yan Jiao et al.
BLOOD (2009)
Role of nitroso radicals as drug targets in circulatory shock
Emanuela Esposito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
Damla Pinar Karpinar et al.
EMBO JOURNAL (2009)
Glutathione-a review on its role and significance in Parkinson's disease
Heather L. Martin et al.
FASEB JOURNAL (2009)
Inhibition of α-synuclein fibril assembly by small molecules: Analysis using epitope-specific antibodies
Masami Masuda et al.
FEBS LETTERS (2009)
Curcumin inhibits aggregation of α-synuclein
Neeraj Pandey et al.
ACTA NEUROPATHOLOGICA (2008)
Curcumin as Curecumin:: From kitchen to clinic
Ajay Goel et al.
BIOCHEMICAL PHARMACOLOGY (2008)
The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery
Garima Dutta et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Curcumin binds to the α-helical intermediate and to the amyloid form of prion protein -: a new mechanism for the inhibition of PrPSc accumulation
Iva Hafner-Bratkovic et al.
JOURNAL OF NEUROCHEMISTRY (2008)
MPP+-induced cytotoxicity in neuroblastoma cells:: Antagonism and reversal by guanosine
Kathleen M. Pettifer et al.
PURINERGIC SIGNALLING (2007)
Role of nitric oxide in the brain during lipopolysaccharide-evoked systemic inflammation
Grzegorz A. Czapski et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders
Cesare Mancuso et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection
M. C. Quilty et al.
EXPERIMENTAL NEUROLOGY (2006)
Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro
K Ono et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Iron chelation in the biological activity of curcumin
Y Jiao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions
GM Cole et al.
NEUROBIOLOGY OF AGING (2005)
Antioxidant capacity of some herbs/spices from Cameroon: A comparative study of two methods
GA Agbor et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo
FS Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
α-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells -: Intermediacy of transferrin receptor iron and hydrogen peroxide
SV Kalivendi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inactivation of human Cu,Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical
B Alvarez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Oxidative stress in neurodegeneration: cause or consequence?
JK Andersen
NATURE MEDICINE (2004)
Lower risk of Parkinson's disease in an admixed population of European and Indian origins
M Ragothaman et al.
MOVEMENT DISORDERS (2003)
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
DC Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Glutathione, iron and Parkinson's disease
S Bharath et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Stabilization of partially folded conformation during α-synuclein oligomerization in both purified and cytosolic preparations
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles
D Sulzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Structure-activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues
P Venkatesan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Share Paper
